首页 > 最新文献

Journal of Developing Drugs最新文献

英文 中文
Pharmacokinetics and toxicity challenges to delivery of cancer nanomedicines 癌症纳米药物传递的药代动力学和毒性挑战
Pub Date : 2020-01-01 DOI: 10.35248/2329-6631.20.09.200
R. Dixit
Nanomedicines are increasingly being used to diagnose, prevent and treat human diseases. Nanotechno- logical advances are enabling targeted delivery of difficult to deliver innovative therapies, including gene editing and disease correcting gene delivery, highly lipophilic cytotoxic cancer drugs, mod RNA, etc. Although nanomedicines offer great opportunities for targeted delivery, they have increasingly faced safety, disposi- tion, CMC and manufacturing challenges that have limited their utility.
纳米医学越来越多地被用于诊断、预防和治疗人类疾病。纳米技术的进步使难以实现的创新疗法得以靶向递送,包括基因编辑和疾病纠正基因递送、高度亲脂性细胞毒性癌症药物、mod RNA等。尽管纳米药物为靶向递送提供了巨大的机会,但它们越来越多地面临安全、处置、CMC和制造方面的挑战,这些挑战限制了它们的应用。
{"title":"Pharmacokinetics and toxicity challenges to delivery of cancer nanomedicines","authors":"R. Dixit","doi":"10.35248/2329-6631.20.09.200","DOIUrl":"https://doi.org/10.35248/2329-6631.20.09.200","url":null,"abstract":"Nanomedicines are increasingly being used to diagnose, prevent and treat human diseases. Nanotechno- logical advances are enabling targeted delivery of difficult to deliver innovative therapies, including gene editing and disease correcting gene delivery, highly lipophilic cytotoxic cancer drugs, mod RNA, etc. Although nanomedicines offer great opportunities for targeted delivery, they have increasingly faced safety, disposi- tion, CMC and manufacturing challenges that have limited their utility.","PeriodicalId":15589,"journal":{"name":"Journal of Developing Drugs","volume":"103 1","pages":"5-5"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84653975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sensitivity pattern of antimicrobials against uropathogens and extend- edspectrum beta lactamase-producing isolates in clinical specimens from the najran region, KSA 沙特阿拉伯纳季兰地区临床标本中抗尿路病原体和广谱β -内酰胺酶产生菌株的敏感性模式
Pub Date : 2020-01-01 DOI: 10.35248/2329-6631.20.09.201
S. Alkahtani
This study analyzed drug prescribing patterns for urinary tract infections (UTIs) among patients aged 12–80 years, male and female and assessed drug use in such cases. Comprised a quantitative, drug prescribing observational study and employed more than 90 confirmed cases of UTIs. The specimens investigated were collected from different hospitals in the Najran Region of the Kingdom of Saudi Arabia (KSA) and the Stokes technique was used to observe the sensitivity pattern of the isolates. The analyses showed 90.0% of total iso- lated organisms were Gram-negative bacteria.
本研究分析了12-80岁男性和女性尿路感染患者的药物处方模式,并评估了这些病例的药物使用情况。包括一项定量的药物处方观察性研究,并采用了90多例确诊的尿路感染病例。所调查的标本是从沙特阿拉伯王国纳吉兰地区的不同医院收集的,并使用Stokes技术观察分离株的敏感性模式。分析结果表明,90.0%的同种相关菌为革兰氏阴性菌。
{"title":"Sensitivity pattern of antimicrobials against uropathogens and extend- edspectrum beta lactamase-producing isolates in clinical specimens from the najran region, KSA","authors":"S. Alkahtani","doi":"10.35248/2329-6631.20.09.201","DOIUrl":"https://doi.org/10.35248/2329-6631.20.09.201","url":null,"abstract":"This study analyzed drug prescribing patterns for urinary tract infections (UTIs) among patients aged 12–80 years, male and female and assessed drug use in such cases. Comprised a quantitative, drug prescribing observational study and employed more than 90 confirmed cases of UTIs. The specimens investigated were collected from different hospitals in the Najran Region of the Kingdom of Saudi Arabia (KSA) and the Stokes technique was used to observe the sensitivity pattern of the isolates. The analyses showed 90.0% of total iso- lated organisms were Gram-negative bacteria.","PeriodicalId":15589,"journal":{"name":"Journal of Developing Drugs","volume":"9 1","pages":"6-6"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91122360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug Development: The Journey of a Medicine from Lab to Shelf 药物开发:一种药物从实验室到货架的历程
Pub Date : 2020-01-01 DOI: 10.35248/2329-6631.20.9.E155
M. Omejc
Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing, followed by trials in humans to determine the efficacy of the drug. Journal of Developing Drugs is a peer reviewed journal, which extensively brings to you the contemporary discoveries and developments in the world of science and medicine.
药物开发是指开发一种新药的过程,这种新药可以有效地针对细胞中的特定弱点。这一过程包括具体的临床前开发和测试,然后进行人体试验以确定药物的功效。《药物开发杂志》是一本同行评议的杂志,它广泛地为您带来当代科学和医学领域的发现和发展。
{"title":"Drug Development: The Journey of a Medicine from Lab to Shelf","authors":"M. Omejc","doi":"10.35248/2329-6631.20.9.E155","DOIUrl":"https://doi.org/10.35248/2329-6631.20.9.E155","url":null,"abstract":"Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing, followed by trials in humans to determine the efficacy of the drug. Journal of Developing Drugs is a peer reviewed journal, which extensively brings to you the contemporary discoveries and developments in the world of science and medicine.","PeriodicalId":15589,"journal":{"name":"Journal of Developing Drugs","volume":"30 1","pages":"1-2"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90249923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 42
Cellular current controversies in pharmaceutical costs in the US and the free market competition solution 蜂窝目前在美国药品成本争议和自由市场竞争的解决方案
Pub Date : 2020-01-01 DOI: 10.35248/2329-6631.20.09.197
C. M. Wax
Pharmaceutical prices in the United States, both proprietary brand names and generics have skyrocketed over the last two decades. The prices of generics, although there are multiple worldwide manufacturers, have gone up exponentially. One of the significant costs drivers in the United States are the PBM,’s pharmacy benefits managers, middlemen. Author presentation will document this and a solution to the problem will be presented. He will show that the repeal of the PBM Safeharbor granted by the federal government in two, has resulted in major price increases. If the safe harbor is removed, prices will plummet to a stable point.He will show that the repeal of the PBM Safeharbor granted by the US federal government in 2002, has resulted in major price increases. If the PBM Safe-harbor is removed, prices will plummet to a stable point as determined by market forces.
在过去的二十年里,美国的药品价格,无论是专利品牌还是仿制药,都在飙升。仿制药的价格,虽然有多个全球制造商,已呈指数级增长。在美国,一个重要的成本驱动因素是PBM,药房福利管理人员,中间商。作者的报告将记录这一点,并提出解决问题的办法。他将证明联邦政府在两年内批准的PBM安全港的废除导致了价格的大幅上涨。如果安全港被移除,价格将暴跌至一个稳定的点。他将表明,2002年美国联邦政府批准的PBM安全港的废除导致了价格的大幅上涨。如果PBM安全港被取消,价格将暴跌到一个由市场力量决定的稳定点。
{"title":"Cellular current controversies in pharmaceutical costs in the US and the free market competition solution","authors":"C. M. Wax","doi":"10.35248/2329-6631.20.09.197","DOIUrl":"https://doi.org/10.35248/2329-6631.20.09.197","url":null,"abstract":"Pharmaceutical prices in the United States, both proprietary brand names and generics have skyrocketed over the last two decades. The prices of generics, although there are multiple worldwide manufacturers, have gone up exponentially. One of the significant costs drivers in the United States are the PBM,’s pharmacy benefits managers, middlemen. Author presentation will document this and a solution to the problem will be presented. He will show that the repeal of the PBM Safeharbor granted by the federal government in two, has resulted in major price increases. If the safe harbor is removed, prices will plummet to a stable point.He will show that the repeal of the PBM Safeharbor granted by the US federal government in 2002, has resulted in major price increases. If the PBM Safe-harbor is removed, prices will plummet to a stable point as determined by market forces.","PeriodicalId":15589,"journal":{"name":"Journal of Developing Drugs","volume":"5 1","pages":"2-2"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80039164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Operation room IV medication management 手术室静脉用药管理
Pub Date : 2020-01-01 DOI: 10.35248/2329-6631.20.09.199
K. Ahmad
Operation room IV Medication Management will discuss the automated device system and activation in the operating room. Discuss the customized IV medication management system. Discuss the experience at CCAD with OR IV Medication management. Completely automated system using automated dispensing machines and computerized physician order entry. ADM and stock of medication in op- erating room are completely managed and controlled by pharmacist.
手术室IV用药管理将讨论手术室的自动化设备系统和激活。探讨定制化静脉用药管理系统。讨论CCAD手术室静脉用药管理的经验。完全自动化的系统,使用自动配药机和计算机化的医嘱输入。手术室的ADM和药物储备完全由药剂师管理和控制。
{"title":"Operation room IV medication management","authors":"K. Ahmad","doi":"10.35248/2329-6631.20.09.199","DOIUrl":"https://doi.org/10.35248/2329-6631.20.09.199","url":null,"abstract":"Operation room IV Medication Management will discuss the automated device system and activation in the operating room. Discuss the customized IV medication management system. Discuss the experience at CCAD with OR IV Medication management. Completely automated system using automated dispensing machines and computerized physician order entry. ADM and stock of medication in op- erating room are completely managed and controlled by pharmacist.","PeriodicalId":15589,"journal":{"name":"Journal of Developing Drugs","volume":"6 1","pages":"4-4"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91422524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Famasi Jamii - Taking pharmacy to the community Famasi Jamii -将药房带到社区
Pub Date : 2020-01-01 DOI: 10.35248/2329-6631.20.09.198
J. Mugisha
Famasi Jamii is a fully registered program that focuses on the provision of information about medicines that are used by the community, including their proper use and handling. Author also provides education, with the aim increasing awareness, on various issues of public health importance. According to reports from the World Health Organization (WHO), patients’ adherence to treatment regimens is lower in middle and low income countries, probably one of the reasons being the lack of appropriate information about the medicines. Improp- er use of medicines (antibiotics particularly) is also a major cause of antimicrobial resistance (AMR), a serious problem that has jeopardized public health.
Famasi Jamii是一个完全注册的项目,重点是提供有关社区使用药物的信息,包括药物的正确使用和处理。提交人还提供教育,目的是提高对各种公共卫生重要性问题的认识。根据世界卫生组织(世卫组织)的报告,中低收入国家的患者对治疗方案的依从性较低,原因之一可能是缺乏有关药物的适当信息。滥用药物(特别是抗生素)也是造成抗菌素耐药性的一个主要原因,这是一个危害公众健康的严重问题。
{"title":"Famasi Jamii - Taking pharmacy to the community","authors":"J. Mugisha","doi":"10.35248/2329-6631.20.09.198","DOIUrl":"https://doi.org/10.35248/2329-6631.20.09.198","url":null,"abstract":"Famasi Jamii is a fully registered program that focuses on the provision of information about medicines that are used by the community, including their proper use and handling. Author also provides education, with the aim increasing awareness, on various issues of public health importance. According to reports from the World Health Organization (WHO), patients’ adherence to treatment regimens is lower in middle and low income countries, probably one of the reasons being the lack of appropriate information about the medicines. Improp- er use of medicines (antibiotics particularly) is also a major cause of antimicrobial resistance (AMR), a serious problem that has jeopardized public health.","PeriodicalId":15589,"journal":{"name":"Journal of Developing Drugs","volume":"93 1","pages":"3-3"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78016345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of novel methodologies for the synthesis of ind-2-enone and piperidine-2, 6-dione frameworks using Baylis-Hillman adducts 利用Baylis-Hillman加合物合成吲哚-2-烯酮和哌啶- 2,6 -二酮框架的新方法的发展
Pub Date : 2020-01-01 DOI: 10.35248/2329-6631.20.09.202
D. V. Lenin
The present day synthetic chemistry demands development of novel carboncarbon bond forming reactions based on the concept of environmental protection. Synthetic chemists have been working in this direction for the last several years. The Baylis-Hillman reaction is one such reaction developed in recent years, on the basis of concepts of atom economy and organo-catalysis that are most important components of environmental protection. Ind-2- en-1- one framework represents an important class of carbocyclic molecules because these derivatives are found in important natural products.
当今的合成化学要求在环保的基础上开发新的碳-碳键形成反应。合成化学家在过去的几年里一直在这个方向上努力。Baylis-Hillman反应就是近年来在原子经济和有机催化的概念基础上发展起来的一种反应,而原子经济和有机催化是环境保护的重要组成部分。Ind-2- en-1- 1框架代表了一类重要的碳环分子,因为这些衍生物存在于重要的天然产物中。
{"title":"Development of novel methodologies for the synthesis of ind-2-enone and piperidine-2, 6-dione frameworks using Baylis-Hillman adducts","authors":"D. V. Lenin","doi":"10.35248/2329-6631.20.09.202","DOIUrl":"https://doi.org/10.35248/2329-6631.20.09.202","url":null,"abstract":"The present day synthetic chemistry demands development of novel carboncarbon bond forming reactions based on the concept of environmental protection. Synthetic chemists have been working in this direction for the last several years. The Baylis-Hillman reaction is one such reaction developed in recent years, on the basis of concepts of atom economy and organo-catalysis that are most important components of environmental protection. Ind-2- en-1- one framework represents an important class of carbocyclic molecules because these derivatives are found in important natural products.","PeriodicalId":15589,"journal":{"name":"Journal of Developing Drugs","volume":"27 1","pages":"7-7"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74799046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phytosomes: A Modernistic Approach for Novel Herbal Drug Delivery - Enhancing Bioavailability and Revealing Endless Frontier ofPhytopharmaceuticals 磷脂体:一种新型草药药物传递的现代方法——提高生物利用度,揭示植物药的无尽前沿
Pub Date : 2019-01-01 DOI: 10.35248/2329-6631.20.9.195
Sudhir Kumar, Ashish Baldi, D. Sharma
Phytopharmaceuticals are healing the world from millions and billions of years even though their clinical validation is questioned by virtue of their impediments like low lipid solubility, poor stability, large size moiety and needless metabolism in gut. Phytosome technology has emerged as committed and promising targeting novel drug delivery with improved efficacy, quality and target ability of active plant constituents. Novel herbal formulation techniques have assured the researchers to deliver the plant based secondary metabolites to their systemic targets. This review highlights the unique properties of phytophospholipid complex along with their application in the novel natural drug delivery. Various methods employed in phytosomal preparation and characterization along with the phytosomal advantages over conventional herbal extracts is described in the present review. The prospectus of phytosome technique can suggest new directions and endless frontier as novel drug regimen.
植物药从数百万年到数十亿年一直在治愈世界,尽管它们的临床有效性受到质疑,因为它们的障碍,如低脂溶性,稳定性差,大尺寸部分和不必要的肠道代谢。光复体技术已成为一种有前途的新型靶向药物递送技术,它能提高植物活性成分的疗效、质量和靶向性。新的草药配方技术使研究人员能够将植物次生代谢物传递到其系统目标。本文综述了植物磷脂复合物的独特性质及其在新型天然药物传递中的应用。在目前的综述中描述了用于植体制备和表征的各种方法以及相对于传统草药提取物的植体优势。植物体技术作为一种新的药物治疗方案,具有广阔的应用前景。
{"title":"Phytosomes: A Modernistic Approach for Novel Herbal Drug Delivery - Enhancing Bioavailability and Revealing Endless Frontier ofPhytopharmaceuticals","authors":"Sudhir Kumar, Ashish Baldi, D. Sharma","doi":"10.35248/2329-6631.20.9.195","DOIUrl":"https://doi.org/10.35248/2329-6631.20.9.195","url":null,"abstract":"Phytopharmaceuticals are healing the world from millions and billions of years even though their clinical validation is questioned by virtue of their impediments like low lipid solubility, poor stability, large size moiety and needless metabolism in gut. Phytosome technology has emerged as committed and promising targeting novel drug delivery with improved efficacy, quality and target ability of active plant constituents. Novel herbal formulation techniques have assured the researchers to deliver the plant based secondary metabolites to their systemic targets. This review highlights the unique properties of phytophospholipid complex along with their application in the novel natural drug delivery. Various methods employed in phytosomal preparation and characterization along with the phytosomal advantages over conventional herbal extracts is described in the present review. The prospectus of phytosome technique can suggest new directions and endless frontier as novel drug regimen.","PeriodicalId":15589,"journal":{"name":"Journal of Developing Drugs","volume":"19 1","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73472916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Phyto-therapeutic investigation of selected Lebanese medicinal plants 选定的黎巴嫩药用植物的植物治疗研究
Pub Date : 2018-05-28 DOI: 10.4172/2329-6631-C1-025
M. Aboul-Ela
{"title":"Phyto-therapeutic investigation of selected Lebanese medicinal plants","authors":"M. Aboul-Ela","doi":"10.4172/2329-6631-C1-025","DOIUrl":"https://doi.org/10.4172/2329-6631-C1-025","url":null,"abstract":"","PeriodicalId":15589,"journal":{"name":"Journal of Developing Drugs","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76057762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changing diameters of drops of atomized liquid for pneumatic nebulization 改变雾化液滴直径,用于气动雾化
Pub Date : 2018-05-28 DOI: 10.4172/2329-6631-C1-027
M. Matuszak, M. Ochowiak, S. Włodarczak
{"title":"Changing diameters of drops of atomized liquid for pneumatic nebulization","authors":"M. Matuszak, M. Ochowiak, S. Włodarczak","doi":"10.4172/2329-6631-C1-027","DOIUrl":"https://doi.org/10.4172/2329-6631-C1-027","url":null,"abstract":"","PeriodicalId":15589,"journal":{"name":"Journal of Developing Drugs","volume":"28 1","pages":"37-37"},"PeriodicalIF":0.0,"publicationDate":"2018-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79680032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Journal of Developing Drugs
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1